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Abstract: Flavonoids have been reported to exert antihyperglycemic effects and have potential
to enhance the current therapy options against type 2 diabetes mellitus. However, the structure
activity relationships (SAR) studies of flavonoids against this disease have not been thoroughly
comprehended. Hence, in the present study, 14 structurally related flavonoids viz. wogonin,
techtochrysin, norwogonin, isoscutellarein, hypolaetin, kaempferol, quercetin, methyl ether of wogonin,
acetate of wogonin, acetate of norwogonin, 8-hydroxy-7-methoxyflavone, chrysin, (+)-catechin and
(-)-epicatechin were taken into account for in vitro antidiabetic evaluation. Cell viability of RIN-5F
pancreatic cells and 3T3-L1 pre-adipocyte cells was initially tested, then an insulin secretion assay of
RIN-5F as well as adipogenesis and glucose uptake measurements of adipocyte were investigated.
Subsequently, protein expressions study through adipokines measurement (leptin, adiponectin, TNF-α,
RBP-4) via enzyme-linked immunosorbent assay (ELISA) kit, Western blotting analysis against GLUT4
and C/EBP-α as well as molecular docking against GLUT1 were analyzed. The results from cell
culture antidiabetic assays (insulin secretion, adipogenesis, and glucose uptake), protein expressions
and molecular docking pointed that the methoxy group at position C-8 is responsible for antidiabetic
property of selected flavonoids via glucose uptake mechanism indicated by up regulation of GLUT4
and C/EBP-α expressions. The mechanism could be enhanced by the addition of an acetate group at
C-5 and C-7 of the flavone skeleton.
Keywords: flavonoids; type 2 diabetes mellitus; RIN-5F pancreatic cells; 3T3-L1 pre-adipocytes;
adipokines; SAR; molecular docking
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1. Introduction
Type 2 diabetes mellitus (T2DM) is a common disease responsible for significant morbidity and
mortality around the world. According to the American Diabetes Association, this disease is one of the
major metabolic disorders that continue to present a significant health problem worldwide and mostly
associated with chronic disturbances in protein, carbohydrate and lipid metabolisms. It is a serious
debilitating disease that has now reached an epidemic proportion and is on the rise at an alarming
rate [1].
Figure 1 depicts the pathophysiology of T2DM where pancreas dysfunction causes
altered/reduced insulin secretion, increased lipolysis and free fatty acid (FFA) levels, low glucose
uptake and inappropriate adipokines (i.e., retinol binding protein (RBP)-4, leptin, tumor necrosis
factor (TNF)-α,) released by adipose tissues. Under these conditions, the glucose-sensitive tissues
(i.e., skeletal muscle and adipocytes) are unable to accommodate the increase in glucose concentration.
In addition, a low level of insulin stimulates the liver to increase glucose production into the blood
stream [2]. On the other hand, hyperglycaemia develops in type 2 diabetes and occurs when there is an
imbalance of glucose production (e.g., aberrant hepatic glucose production during fasting) and glucose
intake (e.g., food consumption) as opposed to insulin-stimulated glucose uptake in target tissues,
mainly skeletal muscles, fat tissue and liver [3]. This condition contributes directly to both insulin
resistance and impairs pancreatic β-cell function, which is described as glucose toxicity. Persistent
glucose release prolongs the hyperglycaemic environment, leading ultimately to T2DM [4].
Figure 1. Pathophysiology of type 2 diabetes mellitus (T2DM).
Flavonoids are a class of plant secondary metabolites that have well categorized structure function
relationships. They are abundantly found in vegetables, fruits, herbs, tea, cocoa, soy, red wine and other
plant food and beverage products. Flavonoids are well reputed as antioxidants in nature, however,
they also can act as an antihyperglycemic agent as has been demonstrated by several researchers [5–10].
It has also been reported that flavonoids can function as insulin secretagogue or insulin mimetic [11],
probably by influencing the pleiotropic mechanisms, to attenuate the diabetic complications [12].
Furthermore, flavonoids have been found to stimulate glucose uptake in peripheral tissues and
regulate the activity and/or expression of the rate-limiting enzymes that are involved in carbohydrate
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metabolism pathway [9,13]. Numerous researchers have investigated the potent activity of flavonoids
against diabetes mellitus [14,15]. As a result, flavonoids are currently considered as one of the most
promising and significantly important class of natural products to enrich the current therapy choices
against type-2 diabetes mellitus.
Although there are only a few studies on the structure activity relationship (SAR) analysis
of flavonoids isolated from different medicinal plants as far as their antidiabetic potential is
concerned [8,9,14,16], the SAR studies to understand the comprehensive mechanism of antidiabetic
potential of flavonoids are yet to be extensively carried out. Hence, this study was aimed at
investigating the role of methoxy and acetate groups in flavonoids and its analogs owing to the
fact that the antidiabetic activity of flavonoids is affected by the presence of different functional groups.
Therefore, attempts were made to investigate their structure relationship and correlation for in vitro
and in silico antidiabetic effects. It is envisioned that further advancement of this research work may
lead to the development of nutritional products and semi-synthetic analogs that retain substantial
antidiabetic capacity with minimal adverse effects.
2. Materials and Methods
2.1. Chemicals, Reagents and Cells
8-hydroxy-7-methoxyflavone, (+)-catechin, (-)-epicatechin, quercetin (control), ascorbic acid,
trolox, ABTS+ radical, potassium persulphate, xanthine, xanthine oxidase, anhydrous potassium
carbonate, anhydrous sodium sulphate, acetic anhydride, pyridine, 2,2-diphenyl-1-picrylhydrazyl
(DPPH) were purchased from Sigma Aldrich (Singapore). 2,4,6-Tris (2-pyridyl)-s-triazine (TPTZ, 99%),
iron (III) chloride hexahydrate and sodium acetate were purchased from Sigma-Aldrich (St. Louis,
MO, USA). Rin-5F pancreatic cell line and 3T3-L1 preadipocyte cells were bought from ATCC,
Manassas, VA, USA. 96 well plates, 24 well plates and RPMI-1640 media were bought from Gibco,
(San Diego, CA, USA). ELISA kits (mouse RBP-4, mouse leptin, mouse TNF-α, mouse adiponectin)
were bought from Cusabio Biotech Co., Ltd., Houston, TX, USA. An insulin secretion enzyme-linked
immunosorbent assay (ELISA) kit was purchased from Elabscience, Wuhan, China. For Western
blotting, 10% SDS TGX stain free™ FastCast acrylamide gel kits, Immun-Blot® polyvinylidene
difluoride (PVDF), non-fat dried milk were purchased from Bio-Rad, Santa Rosa, CA, USA. Primary
antibodies (β-actin, GLUT-4, PPAR-α, C-ebp/α) were bought from ElabScience, Wuhan, China.
Secondary antibody HRP-conjugated goat anti-rabbit immunoglobulin (Ig) was purchased from
GeneTex, Irvine, CA, USA. Chemiluminescence, Chemi-Lumi One L and Tween-20 were bought from
Nacalai-tesque, Kyoto, Japan.
2.2. Compounds’ Isolation and Derivatisation
Three flavones namely; wogonin, norwogonin and techtochrysin were isolated from leaves of
Tetracera indica using the method described by Alhassan et al. [17]. Similarly, two flavones (hypolaetin
and isoscutellarein) and two flavonols (kaempferol and quercetin) were isolated from leaves of Tetracera
scandens following the procedure described by Sarian et al. [9]. Wogonin and norwogonin were
subjected to semi-synthesis to afford their methyl ether and acetate derivatives [9]. These compounds’
structures were characterized by spectroscopic analysis (nuclear magnetic resonance (NMR), infrared
(IR), ultraviolet (UV), mass spectrometry). Their spectral data were further compared with the
previously reported spectral data of the similar compounds already isolated from different plants to
ensure their correct structures (Figure 2).
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Figure 2. Structures of the tested flavonoids; (a) MN1-MN12, (b) (+)-Catechin (MN13), (c) (-)-Epicatechin
(MN14). Wogonin (MN1) → R5 = OH, R7 = OH, R8 = OMe. Methyl ether of wogonin (MN2) →
R5 = OMe, R7 = OMe, R8 = OMe. Acetate of wogonin (MN3) → R5 = OAc, R7 = OAc, R8 = OMe.
Techtochrysin (MN4) → R5 = OH, R7 = OMe. 8-Hydroxy-7-methoxyflavone (MN5) → R7 = OMe,
R8 = OH. Chrysin (MN6)→ R5 = OH, R7 = OH. Norwogonin (MN7)→ R5 = OH, R7 =OH, R8 = OH.
Acetate of norwogonin (MN8)→ R5 = OAc, R7 = OAc, R8 = OAc. Isoscutellarein (MN9)→ R5 = OH,
R7 = OH, R8 = OH, R4′ = OH. Hypolaetin (MN10)→ R5 = OH, R7 = OH, R8 = OH, R3′ = OH, R4′ = OH.
Kaempferol (MN11)→ R3 = OH, R5 = OH, R7 = OH, R4′ = OH. Quercetin (MN12)→ R3 = OH, R5 = OH,
R7 = OH, R3′ = OH, R4′ = OH.
2.3. In Vitro Antidiabetic Evaluation
2.3.1. Cell Viability Assay (RIN-5F Pancreatic Cells and 3T3-L1 Adipocyte Cells)
The RIN-5F pancreatic cells originated from islet cell tumor of rat (ATCC® CRL-2058™) were
seeded at density of 1.0 × 104 cells/well in 96-wells plate and allowed for attachment at 37 ◦C for
72 h [18]. The cells were exposed to the compounds (0.78–100 µg/mL) for 24 h at 37 ◦C in humidified
5% CO2 atmosphere. The 3T3-L1 adipocyte cells originating from mouse embryos (ATCC® CL-173™)
were seeded in 96-wells plate at density of 2.0× 105 cells/well, and allowed for attachment overnight at
37 ◦C. The medium was removed and was replaced with 100 µL medium (pre-treated with compounds
at different concentrations from 0.78–100 µg/mL) for 48 h at 37 ◦C in humidified 5% CO2 atmosphere.
At the termination of the culture, both cells were rinsed with 1X phosphate buffered saline (PBS) and
20 µL of MTT solution (5 mg/mL) was added to each well, and the cells were then cultured for 4 h.
Then, 100 µL of DMSO was added to each well to dissolve formazan crystals and further incubated for
1 h. The optical density (OD) was measured at 570 nm, with reference at 630 nm by a microplate reader
(Infinite M200 Nanoquant Tecan, Männedorf, Switzerland). Cells viability was estimated according to
the stated equation given below [19]:
Viability (%) =
[
(Absorbance sample−Absorbance blank)
(Absorbance control−Absorbance blank)
]
× 100
2.3.2. Insulin Secretion Assay
RIN-5F cells were used to evaluate insulin secretory activity [18]. A quantity of 2.0 × 105
cells/well was seeded in 24-well plates in RPMI 1640 medium. After incubation for 72 h, the medium
was removed. The cells were pre-incubated with 0.5 mL Krebs Ringer bicarbonate (KRB) buffer
supplemented with 1.1 mM glucose, for 40 min at 37 ◦C. The buffer was then replaced with 0.5 mL
KRB buffer solution treated with tested flavonoids, glibenclamide (200 µM) as positive control and
non-treated cells as the negative control. After incubation for 3 h at 37 ◦C, aliquots in all wells
were withdrawn and centrifuged at 1000 rpm for 5 min. The concentration of insulin in the media
was determined by ELISA kits (Elabscience, Wuhan, China) in accordance with the manufacturer’s
instructions and optical density was measured immediately at 450 nm by a microplate reader (Infinite
M200 Nanoquant Tecan, Männedorf, Switzerland).
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2.3.3. Adipogenesis Assay
For adipogenesis, the protocols described by Park et al. [20] and Zhu et al. [21] were followed
with some modifications [22]. Briefly, 5.0 × 105 3T3-L1 preadipocytes were seeded in a 96-wells flat
bottom microplate and induced the adipogenic cocktail after 2 days of the 100% of confluency of the
cells. Then, the adipogenic cocktail (0.5 mM IBMX, 1 µM dexamethasone, 10 µg/mL insulin in DMEM)
and tested compounds (25, 12.5 and 6.25 µg/mL) were added and incubated for 2 days. Untreated cells
were served as control and 10 µM rosiglitazone was served as positive control. After that, the media
was replaced to an insulin media which contained of 10 µg/mL insulin in Dulbecco’s modified Eagle
medium (DMEM) only. Then, at day 4, the media was changed with DMEM in every 2 days until
day 8. Once differentiation of cells had completed, the cells were fixed with 10% formalin for 1 h at
room temperature. Then, the cells were washed 3 times with PBS and stained with 100 µL of freshly
prepared Oil Red O (6 oil red:4 dH2O) per well for 1 h. Cells were again washed with dH2O. After
5 min, 100 µL isopropanol was added per well to lyse the lipid droplets. Finally, the absorbance was
read by microplate reader (Infinite M200 Nanoquant Tecan, Männedorf, Switzerland) at 540 nm.
2.3.4. Fluorescence Glucose Uptake Measurement Assay
The fluorescence glucose uptake (2-NBDG) measurement method described by Hasan et al. [22]
was strictly followed with some modifications. Briefly, 5.0 × 105 of 3T3-L1 preadipocytes were
seeded using a 96-well black fluorescence plate and allowed to grow up to 100% of confluency. After
2 days, the cells were treated with adipogenic cocktail to differentiate into mature adipocytes. Upon
completing the differentiation of 3T3-L1 preadipocyte (on day 8), the cells were made to starve by
incubating in serum and glucose-free DMEM for two days. After that, the 3T3-L1 adipocytes were
further incubated with 80 µM 2-NDBG and tested compounds with 10 µg/mL insulin for another
two days. 10 µM rosiglitazone was served as positive control. The cultures carefully were washed
with 1X PBS to eliminate the remaining 2-NBDG. Lastly, the encapsulated fluorescence in the cells
was measured by fluorescence microplate reader (Perkin Elmer, Rodgou, Germany) at an excitation
wavelength of 485 nm and emission wavelength of 535 nm. The 100% of specific 2-NBDG uptake was
determined by following equation:
Specific Absorbance = Absorbance of insulin induced 2NDBG−Absorbance of non insulin induced 2NDBG
2.4. Molecular Antidiabetic Evaluation
Leptin, Adiponectin, Tumor Necrosis Factor-A (Tnf-A) and Retinol Binding Protein-4 (Rbp-4) Assays
After the completion of the adipogenesis process on day 8, the 3T3-L1 adipocytes were treated
with tested flavonoids at 40 µg/mL for 48 h. Subsequently, supernatants were collected and further
used to evaluate leptin, adiponectin, TNF-α, and RBP-4 adipocytokines (Cusabio Biotech Company,
Limited). Adipocytokines levels were measured using ELISA kits at the wavelength of 450 nm in
accordance with the manufacturer’s instructions. Each experiment was performed in triplicate, and the
results were presented as the means ± SD. Groups of data were compared using one-way analysis of
variance (ANOVA) and Tukey’s multi comparison test.
2.5. Western Blotting Assay
Protein content was quantified according to Nouroozi et al. [23] with some modifications with
bovine serum albumin chosen as a standard. 3T3-L1 adipocyte treated with tested flavonoids,
cell lysates were run on 10% SDS TGX stain free™ FastCast acrylamide kits. Separated proteins
were transferred to Immun-Blot® polyvinylidene difluoride (PVDF), 0.22 µm membranes (Bio-Rad,
Santa Rosa, CA, USA) at 90 volts with cooling, in transfer buffer, Tran-Blot® (Bio-Rad, Santa Rosa,
CA, USA) for 2 h. At the conclusion of the transfer, the membranes were then blocked for 1 h with
5% non-fat dried milk in 20 mmol L−1 Tris–HCl, Tween20, 0.15 mol L−1 NaCl buffer (TBS-Tween),
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pH 8. The membranes were then incubated with primary antibodies 1:1000 (GLUT-4, C/EBP-α and
β-actin goat anti-mouse as the loading reference) in 5% non-fat dried milk in TBS-Tween buffer for 24 h,
then washed several times with TBS-tween buffer. The secondary antibody used for all membranes
was horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (GeneTex, Irvine, CA, USA) at a
dilution of 1:1000, 5% non-fat dried milk in TBS-Tween buffer for 1 h, followed by several washes
as above at a dilution of 1:500 [24]. The membranes were then developed with chemiluminescence,
Chemi-Lumi One L (Nacalai-Tesque, Kyoto, Japan). Proteins were visualised using gel documentation
(Bio-Rad, Santa Rosa, CA, USA) and further analyzed by using Image J software [25].
2.6. In-Silico Molecular Docking of Glucose Transporter 1 (Glut 1)
A molecular docking approach was applied in this study to investigate the potential molecular
targets of tested flavonoids. Molecular docking software named AutoDock 4.2 was used to execute
the docking process. Proteins namely GLUT 1 was used as target for all tested flavonoids. The crystal
structures of the proteins were retrieved from the protein data bank (PDB) and were used as receptors
to perform the molecular docking study. Software including Molecular Graphics Library MGLTools
1.5.6, AutoDock Tools 4.2 [26] and Discovery Studio Visualizer 4.0 [27] were used for the molecular
docking experiments. The 3D structure for GLUT1 (PDB ID: 5EQI) was obtained from the protein data
bank [28]. Crystallographic waters and co-crystallized ligand were removed, polar hydrogens were
added to a macromolecule by using AutoDock 4.2, after which the structure was saved in PDBQT file
format that contains a protein structure with hydrogen in all polar residues. The 2D structures of the
compounds were built with ChemDraw and converted to 3D format using ChemBio3D and saved
in PDB file format. The ligands were then prepared for docking by computing the charges and the
structures were saved in PDBQT file format via AutoDock 4.2 [29].
A molecular docking experiment of ligands was carried out using crystal structure of human
glucose transporter GLUT1 co-crystallized with cytochalasin B (PDB ID: 5EQI). The size and centre
coordinates of the grid box were first validated by re-docking the co-crystallized ligand on binding
sites of the receptor. The rotational bonds of the ligands were treated as flexible while those of the
protein were kept rigid. Grid boxes were fixed around the cytochalasin B binding site using the
ligand as the grid box centre. The box size was set to 60, 60 and 60 Å3 (x, y and z respectively) and
the grid spacing to 0.375 Å. The grid maps for atoms were calculated for all the ligands. A genetic
algorithm (GA) was used for searching and the population size was set to 150, 100 runs and 5 million
energy evaluations. Potential ligands (based on fluorescent glucose uptake and Western blotting result)
were then docked into the active site of the enzyme using the grid box parameter obtained from the
redocking of co-crystallized ligand as reference.
2.7. Statistical Analysis
Data were collected and expressed as the mean ± standard deviation (SD) of three independent
experiments and analysed for statistical significance from each control. The data were tested for
statistical differences by one-way ANOVA followed by Tukey or Dunnet’s multiple comparison tests
of MiniTab (version 18). The criterion for significance was set at p < 0.05.
3. Results
3.1. In Vitro Antidiabetic Evaluation
3.1.1. Viability Study of RIN-5F Pancreatic Cells
Figure 3 displays the percentage of cell viability of RIN-5F pancreatic measured by MTT assay
from 25.0–0.39 µg/well in 1 h of tested flavonoids treatment for screening purpose. Results showed
that wogonin (MN1) revealed significant toxicity at all concentrations (p < 0.05). Meanwhile, acetate of
wogonin (MN3), acetate of norwogonin (MN8) and quercetin (MN12) showed the IC50 value at 6.25
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µg/well, whereas isoscutellarein (MN9), hypolaetin (MN10), (+)-catechin (MN13) and (-)-epicatechin
(MN14) showed good cell viability at all concentrations. From this result, the lowest concentration
(0.39 µg/well) was chosen for the insulin secretion assay for all the tested flavonoids.
Figure 3. The percentage of cell viability of RIN-5F ranging from 0.39–25 µg/well in 1 h. Mean ±
standard deviation (S.D.), n = 3, small letters represent Dunnet’s test. Mean values that do not share a
letter are significantly different (p < 0.05).
3.1.2. Insulin Secretion Assay (Rin-5F Pancreatic Cells)
Figure 4 portrays the effect of tested flavonoids on the insulin secretion activity of RIN-5F
pancreatic cell line as compared to glibenclamide (positive control). The graph shows that, at 0.39
µg/mL, acetate of norwogonin (MN3) and hypolaetin (MN10) showed the highest insulin release,
similar to glibenclamide (positive control), followed by methyl ether of wogonin (MN2), kaempferol
(MN11), (+)-catechin (MN13), acetate of norwogonin (MN8), (-)-epicatechin (MN14), quercetin (MN12),
8-hydroxy-7-methoxyflavone (MN5), chrysin (MN6), norwogonin (MN7) and isoscutellarein (MN9).
Meanwhile, wogonin (MN1), and techtochrysin were shown to hamper the insulin secretion as
compared to non-treated control (p < 0.05).
Figure 4. The effect of the flavonoid on insulin secretion activity of RIN-5F pancreatic cells. Mean ± S.D.,
n = 3, means that do not share a letter are significantly different (p < 0.05).
Biomolecules 2018, 8, 149 8 of 22
3.1.3. Viability Study of 3T3-L1 Preadipocyte Cells
Figure 5 demonstrates the percentage of cell viability of 3T3-L1 preadipocyte cells measured by
MTT assay from 0.78–100 µg/well for 48 h. Result exhibited that the cell viability was decreased as
the concentration of the tested flavonoids increased. At 0.78 µg/well, cells showed 100% viability
or more of all groups (MN1-MN14) as compared to the non-treated control. As the concentration
slightly increased from 1.56 to 25.0 µg/well, the viability was decreased above the IC50 values. IC50
value of chrysin (MN6) and norwogonin (MN7) began to reach at 50 µg/well, and at 100 µg/well,
wogonin (MN1), methyl ether of wogonin (MN2), acetate of wogonin (MN3), techtochrysin (MN4),
8-hydroxy-7-methoxyflavone (MN5) and kaempferol (MN11) showed toxicity effect while norwogonin
(MN7), acetate of norwogonin (MN8), isoscutellarein (MN9), hypolaetin (MN10), quercetin (MN12),
(-)-epicatechin (MN14) and (+)-catechin (MN13) showed IC50 values higher. From this result,
concentrations of treatments below 25.0 µg/well were considered as safe to be used for further study.
Figure 5. The percentage of cell viability of 3T3-L1 preadipocyte cells measured by MTT assay, ranging
from 0.78 to 100 µg/well for 48 h. Small letters represent Dunnet’s test. Mean ± S.D., n = 3, means
values that do not share a letter are significantly different (p < 0.05).
3.1.4. Adipogenesis (Oil Red O Staining)
Figure 6 shows the quantification of lipid droplet from adipogenesis after flavonoids treatment
and were compared to rosiglitazone as the positive control. Results showed that at 25.0 µg/well,
acetates of wogonin (MN3) and norwogonin (MN8) displayed the highest value of lipid droplet
stained by oil red O, followed by norwogonin (MN7), wogonin (MN1), and methyl ether of wogonin
(MN2). However, techtochrysin (MN4), 8-hydroxy-7-methoxyflavone (MN5), and chrysin (MN6) also
showed good lipid droplet formations as compared to non-treated group, (p < 0.05). These groups
exhibited increased in lipid droplet formation in dose dependent manner. It can be observed that
isoscutellarein (MN9), hypolaetin (MN10), kaempferol (MN11), quercetin (MN12), (+)-catechin (MN13)
and (-)-epicatechin (MN14) showed average lipid droplet formation, however not in a dose-dependent
manner, as compared to other flavonoids groups.
Figure 7 illustrates the microscopic observation under 40×magnification of lipid droplet stained
by oil red O stain by all tested flavonoids at 25 µg/well. It can be observed that rosiglitazone at 10 µM
(positive control) showed the most lipid droplet followed by acetate of norwogonin (MN8), acetate of
wogonin (MN3), norwogonin (MN7), wogonin (MN1) and methyl ether of wogonin (MN2). The rest
of the groups showed average lipid droplet formation as compared to the non-treated group (N-T).
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Figure 6. Quantification of lipid droplet after treatment. Small letters represent Tukey’s test. Mean ± S.D.,
n = 3, means values that do not share a letter are significantly different (p < 0.05).
Figure 7. Lipid droplets formations of 3T3-L1 adipocyte cells stained with Oil red O. Magnification
40×. (NT: non-treated, MN1: wogonin, MN2: methyl ether of wogonin, MN3: acetate of wogonin,
MN4: techtochrysin, MN5: 8-hydroxy-7-methoxyflavone, MN6: chrysin, MN7: norwogonin, MN8:
acetate of norwogonin, MN9: isoscutellarein, MN10: hypolaetin, MN11: kaempferol, MN12: quercetin,
MN13: (+)-catechin and MN14: (-)-epicatechin).
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3.1.5. Fluorescent Glucose [2-NDBG] Uptake Measurement
Figure 8 illustrates the effect of flavonoids on glucose [2-NDBG] uptake measurement of 3T3-L1
adipocyte cells. The result showed that at 6.25 µg/mL, only hypolaetin (MN10) showed statistically
significant glucose uptake as compared to non-treated control (p < 0.05). At 12.5 and 25 µg/mL,
wogonin (MN1), methyl ether of wogonin (MN2), acetate of wogonin (MN3), techtochrysin (MN4),
8-hydroxy-7-methoxyflavone (MN5) and norwogonin (MN7) showed statistically significant glucose
uptake measurement as compared to the non-treated group (p < 0.05). Rosiglitazone (positive control)
displayed the highest absorbance of the fluorescence at concentration of 10 µM (p < 0.05). It is
observable that, wogonin (MN1), methyl ether of wogonin (MN2), acetate of wogonin (MN3),
techtochrysin (MN4), 8-hydroxy-7-methoxyflavone (MN5), chrysin (MN6), norwogonin (MN7)
and acetate of norwogonin (MN8) showed the glucose [2-NDBG] uptake in a dose-dependent
manner, whereas, isoscutellarein (MN9), hypolaetin (MN10), kaempferol (MN11), quercetin (MN12),
(+)-catechin (MN13), and (-)-epicatechin (MN14) did not follow the same trend of glucose uptake. This
consistent trend has further validated the lipid droplet formation (adipogenesis) result.
Figure 8. The effect of flavonoids on glucose uptake measurement of adipocyte cells. Small letters
represent Tukey’s test. Mean ± S.D., n = 3, means values that do not share a letter are significantly
different (p < 0.05).
3.2. Molecular Antidiabetic Evaluation
3.2.1. Measurement of Adipokines (Leptin, Adiponectin, Tumor Necrosis Factor-A (TNF-A), Retinol
Binding Protein-4 (RBP-4)) of 3T3-L1 Adipocyte Cells Upon Flavonoids Treatment
Figure 9 presents the adipokines measurement originated from 3T3-L1 adipocyte cells viz.,
leptin (a), adiponectin (b), TNF-α (c) and RBP-IV (d) of all tested flavonoids via enzyme-linked
immunosorbent assay (ELISA). For leptin measurement, at 12.5 µg/mL, result of all groups of
tested flavonoids showed statistically reduced in leptin concentration (pg/mL) as compared to
the non-treated group (p < 0.05). However, (-)-epicatechin (MN14) showed the lowest reduction
similar to positive control, rosiglitazone (10 µM), followed by techtochrysin (MN4), isoscutellarein
(MN9), quercetin (M12), (+)-catechin (MN13), wogonin (MN1), 8-hydroxy-7-methoxyflavone (MN5),
norwogonin (MN7), chrysin (MN6), hypolaetin (MN10), kaempferol (MN11), acetate of wogonin
(MN3), acetate of norwogonin (MN8), and methyl ether of wogonin (MN2), respectively.
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• For adiponectin measurement, at 12 µg/mL, except for acetate of norwogonin (MN8) and
kaempferol (MN11), result of the tested flavonoids showed statistically increased in adiponectin
concentration (ng/mL) as compared to the non-treated group (p < 0.05). Hypolaetin (MN10),
showed the highest concentration, followed by isoscutellarein (MN9), norwogonin (MN7),
(-)-epicatechin (MN14), methyl ether of wogonin (MN2), wogonin (MN1), (+)-catechin (MN13),
techtochrysin (MN4), quercetin (MN12), 8-hydroxy-7-methoxyflavone (MN5), acetate of wogonin
(MN3) and chrysin (MN6), respectively.
• For tumor necrosis factor, i.e., α (TNF-α), at 12 µg/mL, except for acetate of norwogonin (MN8),
the result of the tested flavonoids displayed statistically decreased in TNF-α concentration
(ng/mL) as compared to the non-treated group (p < 0.05). Quercetin (MN12) showed the lowest
concentration of TNF-α, followed by (-)-epicatechin (MN14), norwogonin (MN7), kaempferol
(MN11), (+)-catechin (MN13), wogonin (MN1), techtochrysin (MN4), chrysin (MN6), methyl
ether of wogonin (MN2) and the least concentration was shown by the acetate of wogonin
(MN3), respectively.
• Subsequently, for retinol binding protein IV (RBP-IV), at 12 µg/mL, except for techtochrysin
(MN4), result of the tested flavonoids exhibited statistically reduced in RBP-IV concentration
(ng/mL) as compared to the non-treated group (p < 0.05). (-)-epicatechin (MN14) showed
the lowest concentration, followed by kaempferol (MN11), hypolaetin (MN10), norwogonin
(MN7), 8-hydroxy-7-methoxyflavone (MN5), methyl ether of wogonin (MN2), wogonin
(MN1), isoscutellarein (MN9), chrysin (MN6), acetate of norwogonin (MN3), acetate of
norwogonin (MN8), quercetin (MN12), and the least concentration was displayed by (+)-catechin
(MN13), respectively.
3.2.2. Western Blotting
Figure 10 shows the density index of proteins band of glucose transporter 4 (GLUT4) and
CCAAT/enhancer-binding protein α (C/EBP-α) projected from the image of protein bands that
segregated based on the molecular weight on the polyvinylidene difluoride membrane (Figure 11).
β-actin was used as the internal standard to normalize the band of protein interest. For GLUT4
protein, acetate of wogonin (MN3), methyl ether of wogonin (MN2) and wogonin (MN1) showed
significant upregulation expression (p < 0.05). Techtochrysin (MN4) and 8-hydroxy-7-methoxyflavone
(MN5) showed no significant difference with non-treated group, while the rest of the flavonoids
showed slightly upregulation expression, however, these results were not significant as compared to
non-treated group (p > 0.05). For the expression of C/EBP-α, 8-hydroxy-7-methoxyflavone (MN5)
showed the highest expression, followed by norwogonin (MN7), acetate of norwogonin (MN8), methyl
ether of wogonin (MN2), techtochrysin (MN4), wogonin (MN1), and chrysin (MN6) (p < 0.05). The rest
of the flavonoids showed downregulation of C/EBP-α expression (p > 0.05).
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Figure 9. Adipokines measurement of adipocyte after flavonoids treatment at 12.5 µg/mL; (a) leptin, (b) adiponectin, (c) TNF-α, (d) RBP-IV. Mean ± S.D., n = 3, mean
values that do not share a letter are significantly different (p < 0.05).
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Figure 10. The density of protein bands of GLUT4 and C/EBP-α per β-actin. Mean ± S.D., n = 3, mean
values that do not share a letter are significantly different (p < 0.05).
Figure 11. Image of protein bands of GLUT4, C/EBP-α and β-actin (internal control) on polyvinylidene
difluoride (PVDF) membrane.
3.3. In Silico Molecular Docking (GLUT 1)
Table 1 shows the docking scores against GLUT1 indicated by free binding energies. Lower
binding energy depicts better ligand receptor interaction as well as higher docking score. Acetate of
wogonin (MN3) showed the highest docking score (−7.84 kcal/mol) followed by acetate of norwogonin
(MN8) (−7.45 kcal/mol), norwogonin (MN7) (−7.17 kcal/mol), wogonin (MN1) (−7.07 kcal/mol),
methyl ether of wogonin (MN2) (−6.97 kcal/mol) and techtochrysin (MN4) (−6.8 kcal/mol).
Kaempferol (MN11) and (-)-epicatechin (MN14) showed weak binding energy which was calculated
as 7.63 kcal/mol and 7.86 kcal/mol, respectively.
Table 1. Docking score of selected flavonoids against GLUT 1.
Code Ligand Free Binding Energy (kcal/mol)
Control Cytochalasin B (co-crystallize ligand) −10.75
MN1 Wogonin −7.07
MN2 Methyl ether of wogonin −6.97
MN3 Acetate of wogonin −7.84
MN4 Techtochrysin −6.8
MN7 Norwogonin −7.17
MN8 Acetate of norwogonin −7.45
MN11 Kaempferol 7.63
MN14 (-)-Epicatechin 7.86
Figure 12a,b shows the active site of the GLUT1 receptor. The residues of the active sites
were found to be Phe26, Trp412, Asn411, Asn415, Trp388, Gln282, Gln283, Phe379, Asn288, Phe291,
and Tyr292. Among these residues, Asn411, Asn415, Gln282, Gln283, Asn288, Tyr 292 were found to
interact with glucose through hydrogen bonding (Figure 12a).
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Figure 12. Binding interactions of glucose (a) with active site residues of GLUT1 (PDB ID: 5EQI).
The compounds are coloured black while amino acids are green. Green and purple dashes depict
hydrogen bond and hydrophobic bond, respectively. (b) Surface structure of glucose in active site of
GLUT1. Blue and brown colours indicate polar and hydrophobic regions, respectively.
Figure 13 shows the binding interactions of wogonin (MN1) (a), methyl ether of wogonin
(MN2) (b), acetate of wogonin (MN3) (c) and techtochrysin (MN4 (d)). All the four compounds
displayed binding interactions with residues that interact with glucose in the active site, viz., Asn415,
Trp412 and Trp418. Wogonin (MN1) displayed an additional interaction with Gln288 and Gln 282
while flavone-5,7,8-triacetate showed hydrogen bonding with Gln288 and Gln 282, Pro385 and Glu380.
Figure 13. Binding interactions of wogonin (MN1) (a), methyl ether of wogonin (MN2) (b), acetate of
wogonin (MN3) (c), and techtochrysin (MN4) (d) with active site residues of GLUT1 (PDB ID: 5EQI).
The compounds are coloured black while amino acids are green. Green and purple dashes depict
hydrogen bond and hydrophobic bond, respectively.
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Acetate of norwogonin (MN8) (Figure 14) exhibited binding interactions similar to that of acetate
of wogonin (MN3). It exhibited hydrogen bonding interactions with Asn411, Asn288, Trp388, Asn317,
Pro385 and Glu380 while norwogonin formed hydrogen bonding with fewer amino acids which
include Asn288, Gln283, trp415 and Trp388.
Figure 14. Binding interactions of norwogonin (MN7) (a) and acetate of norwogonin (b) with active
site residues of Glut1 (PDB ID: 5EQI). The compounds are coloured black while amino acids are green.
Green and purple dashes depict hydrogen bond and hydrophobic bond, respectively.
Figure 15 shows the binding pattern of kaempferol (MN11) (a) and (-)-epicatechin (MN14) (b),
respectively. Kaempferol (MN11) displayed hydrogen bonding interaction with Asn288, Gln282,
Gln283, Asn411 and Gly408 while (-)-epicatechin (MN14) exhibited hydrogen bonding with Asn288,
Gln282, Asn411, ASn288, Gly408 and Ser30. Both compounds displayed hydrophobic interactions
with Trp412.
Figure 15. Binding interactions of kaempferol (MN11) (a), (-)-epicatechin (MN14) (b) with active site
residues of Glut1 (PDB ID: 5EQI). The compounds are coloured black while amino acids are green.
Green and purple dashes depict hydrogen bond and hydrophobic bond, respectively.
4. Discussion
4.1. In Vitro Antidiabetic Evaluation on RIN-5F Pancreatic Cells and 3T3-L1 Adipocytes
Glucose is the most potent stimulator of insulin secretion and can achieve acute and long-term
regulation of insulin [30]. Nevertheless, some nutrients are also able to activate insulin release
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or intensify glucose-stimulated insulin secretions such as hormones [31,32], proteins [33,34],
and pharmacological agents [35]. In the present study, flavonoids were subjected to a RIN-5F pancreatic
cell to determine the effect of plant-based compounds on insulin secretion stimulation. From the
cell viability of the RIN-5F pancreatic cell, the lowest concentration of flavonoids (0.39 µg/mL) was
applied due to their high cytotoxicity effect against this cell lines. The results showed that the acetate of
wogonin (MN3) from the flavones group revealed the highest insulin secretion. The presence of acetate
group at C-7 and methoxy group at C-8 on a flavone was found to improve the insulin secretagogue
effect. Subsequently, after the acetate of wogonin, the hypolaetin (MN10) showed the highest insulin
release indicative of the presence of catechol system at B ring which may be responsible as one of the
factors to enhance the insulin secretagogue effect similar to glibenclamide. Jayaprakasam et al. [36]
reported that stimulation of insulin secretion from rodent pancreatic β-cell is influenced by the number
of hydroxyl groups at B-ring of flavonoids. Next, methyl ether of wogonin (MN2), kaempferol
(MN11), (+)-catechin (MN13), acetate of norwogonin (MN8), (-)-epicatechin (MN14), quercetin (MN12),
8-hydroxy-7-methoxyflavone (MN5), chrysin (MN6), norwogonin (MN7) and isoscutellarein (MN9)
exhibited moderate insulin secretagogue effect. Meanwhile, wogonin (MN1), and techtochrysin were
shown to hamper insulin secretion ability resulting from the manifestation of the cytotoxicity effect
against the cell lines.
Adipocytes are involved in the development of insulin resistance, resulting from the dysfunction
of insulin signalling pathway [37]. Thus, improving adipocyte function and the complementation or
replacement of poorly functioning adipocytes could be beneficial in T2DM [38]. Adipogenesis can be
initiated by the activation of insulin signalling as well as the glucose uptake pathway, and consequently
has been used for screening the natural compounds with antidiabetic activity. Results from cell viability
of preadipocyte study demonstrated 25.0 µg/well as the safe dose of flavonoids (especially flavones
group). Concentrations higher than 25.0 µg/well were found cytotoxic in nature which was also
supported by the results demonstrated by Hasan et al. [22]. Results of lipid droplet quantification
(adipogenesis) showed that at 25.0 µg/well, acetate of norwogonin (MN8) and acetate of wogonin
(MN3) displayed the highest value of lipid droplet stained by oil red O that revealed about the
importance of acetate group at C-5, C-7 and C-8 in these two compounds. Moreover, methoxy group at
C-8 was also found to improve adipogenesis. Consequently, norwogonin (MN7), wogonin (MN1), and
methyl ether of wogonin (MN2) highlighted the importance of methoxy group at C-7 and C-8 positions.
Techtochrysin (MN4), 8-hydroxy-7-methoxyflavone (MN5), and chrysin (MN6) also showed good
lipid droplet formations as compared to the non-treated group, (p < 0.05). Groups mentioned above
exhibited increased in lipid droplet formation in a dose-dependent manner. On the other hand, it can
be observed that isoscutellarein (MN9), hypolaetin (MN10), kaempferol (MN11), quercetin (MN12),
(+)-catechin (MN13) and (-)-epicatechin (MN14) showed average lipid droplet formation, however not
in a dose-dependent manner, as compared to other flavonoids groups.
According to Shang et al. [39], glucose uptake in adipocyte is the consequence of stimulation of
insulin receptor (i.e., PPARs, GLUTs) by insulin. Research study has shown that the direct uptake of
2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yo)amino]-2-deoxyglucose (2-NDBG) is transported using the
same glucose transporter (GLUT) as D-glucose [40] (Marin-Juez, 2015). The result showed that at
12.5 and 25 µg/mL, wogonin (MN1), methyl ether of wogonin (MN2), acetate of wogonin (MN3),
techtochrysin (MN4), 8-hydroxy-7-methoxyflavone (MN5) and norwogonin (MN7) showed statistically
significant glucose uptake measurement as compared to non-treated group (p < 0.05) that indicated the
importance of methoxy group at position C-8, acetate group at position C-7 and the configuration of
C-5, C-7 and C-8 positions. It is observable that these groups showed the glucose [2-NDBG] uptake in
a dose-dependent manner, whereas, isoscutellarein (MN9), hypolaetin (MN10), kaempferol (MN11),
quercetin (MN12), (+)-catechin (MN13), and (-)-epicatechin (MN14) did not follow the same trend of
glucose uptake. This consistent trend has further validated the lipid droplet formation (adipogenesis)
result. Johnstan et al. [41] reported that (-)-epicatechin demonstrated a marked reduction in glucose
absorption via competitive inhibition of sodium dependent glucose transporter-1 (GLUT-1). Previously,
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Nomura et al. [42] reported that kaempferol and quercetin inhibited insulin signal transduction,
and inhibited the translocation of GLUT4 and uptake of glucose in MC3T3-G2/PA6 adipose cells.
For adipogenesis and 2-NDBG uptake activity, flavonols with methoxy groups showed stronger
effects particularly those with a methoxy group at the C-3 position. Matsuda et al. [16] and
Saito et al. [43] agreed that presence of the methoxy group in flavonoids enhance differentiation
and lipolysis in 3T3-L1 adipocytes. With regard to SAR of flavonoids, it was found that flavonoids with
acetate groups showed stronger effects. The existence of methoxy group also enhanced the activity
particularly those with a methoxy group at the C-7 and C-8-positions. It was also found that flavonoids
that possess a high number of hydroxy groups showed less activity of adipogenesis [16].
4.2. In Vitro Molecular Antidiabetic Evaluation
According to Dunmore and Brown [44], insulin is released from a pancreatic islet in response
to increased blood glucose uptake into the adipocyte via insulin binding and signalling and further
led to increased storage of triacylglycerol. Due to this reason, insulin resistance in adipose tissue
also contributes to β-cells failure and eventually leads to T2DM. Molecules released from adipocyte
(adipokines) are influenced by the flow of uptake and release from the cells. Hence, the present
study investigated the adipokines measurement upon the treatment of flavonoids to find the
association between glucose uptake and adipokines secretion (viz., leptin, adiponectin, TNF-α,
and RBP-IV). For leptin measurement, at 12.5 µg/mL, the result of all groups of tested flavonoids
showed statistically reduced leptin concentration (pg/mL) as compared to the non-treated group
(p < 0.05). However, (-)-epicatechin (MN14) showed the lowest reduction similar to positive control,
rosiglitazone (10 µM) that indicated that ketonic functional group at position C-4 in a flavonoid
molecule is not essential in order to reduce the leptin concentration. This result was further followed
by techtochrysin (MN4), isoscutellarein (MN9), quercetin (M12), (+)-catechin (MN13), wogonin
(MN1), 8-hydroxy-7-methoxyflavone (MN5), norwogonin (MN7), chrysin (MN6), hypolaetin (MN10),
kaempferol (MN11), acetate of wogonin (MN3), acetate of norwogonin (MN8), and methyl ether of
wogonin (MN2), respectively, which indicated that the presence of acetate and methoxy groups slightly
helped to reduce the leptin concentration.
Adiponectin is an adipocyte-derived hormone that reverses insulin resistance associated with
both lipoatrophy and obesity [43]. For adiponectin measurement, at 12 µg/mL, except for acetate of
norwogonin (MN8) and kaempferol (MN11), results of the tested flavonoids showed statistically
increased adiponectin concentration (ng/mL) as compared to the non-treated group (p < 0.05)
which suggested that acetate group is responsible for the inhibition of adiponectin secretion.
Hypolaetin (MN10) showed the highest adiponection concentration, followed by isoscutellarein
(MN9), norwogonin (MN7), (-)-epicatechin (MN14) that highlighted the role of hydroxyl groups
especially in the B ring (catechol) of flavonoids. Methyl ether of wogonin (MN2), wogonin (MN1),
(+)-catechin (MN13), techtochrysin (MN4), quercetin (MN12), 8-hydroxy-7-methoxyflavone (MN5),
acetate of wogonin (MN3) and chrysin (MN6) showed moderate secretion of adiponectin.
Tumor necrosis factor α (TNF-α) is a well-known marker associated with induction of obesity
related to insulin resistance and dyslipidemia [44]. According to Moller [45], neutralization of TNF- α is
able to improve insulin sensitivity. Results showed that at 12 µg/mL, except for acetate of norwogonin
(MN8), results of the tested flavonoids displayed statistically decreased TNF-α concentration (ng/mL)
as compared to the non-treated group (p < 0.05) which revealed that the acetate group did not help
the cells to suppress, whereas the hydroxyl group was able to contain TNF-α production. Quercetin
(MN12) showed the lowest concentration of TNF-α, followed by (-)-epicatechin (MN14), norwogonin
(MN7), kaempferol (MN11), (+)-catechin (MN13) which revealed that the total number of hydroxyl
groups and configuration are essential in suppressing TNF-α in the molecules of flavonoids. Wogonin
(MN1), techtochrysin (MN4), chrysin (MN6), methyl ether of wogonin (MN2) and acetate of wogonin
(MN3) showed moderate TNF-α suppression which clearly indicated that the methoxy group does not
possess strong impact in order to facilitate the cell to go against this marker.
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The liver and adipocytes secrete retinol-binding protein-4 (RBP-4) which affects systemic insulin
sensitivity and glucose homeostasis [46]. Studies have found that serum RBP-4 level is elevated in
insulin-resistant states in mice and humans [46,47]. The present study showed that at 12 µg/mL of
flavonoids treatment exhibited statistically reduced in RBP-IV concentration (ng/mL) as compared
to non-treated group (p < 0.05) except for techtochrysin (MN4). (-)-epicatechin (MN14) showed the
lowest RBP-4 concentration, followed by kaempferol (MN11), hypolaetin (MN10), norwogonin (MN7),
8-hydroxy-7-methoxyflavone (MN5), methyl ether of wogonin (MN2), wogonin (MN1), isoscutellarein
(MN9), chrysin (MN6), acetate of wogonin (MN3), acetate of norwogonin (MN8), quercetin (MN12),
and the least concentration was displayed by (+)-catechin (MN13), respectively. These results further
highlighted the essential features of the total number and configuration of hydroxyl groups in the
flavonoids skeleton. Meanwhile, methoxy and acetate groups in the flavonoids molecules were also
found to increase the effect of flavonoids against this adipokine.
Decrease in the translocation of GLUT-4 protein of the plasma membrane has been found to be the
main cause of the insulin resistance [48]. Moreover, C/EBP-α is one of the major transcriptional factors
leading to adipocyte differentiation, and regulates glucose metabolism and insulin sensitivity [49].
Although the relationship between GLUT 4 and C/EBP-α is unclear, there is a cross-regulation between
both proteins during the adipogenesis process. The density index of GLUT 4 and C/EBP-α proteins
was projected from the image of proteins bands on the PVDF membrane. β-actin was taken as the
internal standard to normalize the proteins’ band. Among all groups, acetate of wogonin (MN3),
methyl ether of wogonin (MN2) and wogonin (MN1) significantly upregulated the GLUT 4 protein
(p < 0.05) which emphasized the importance of the methoxy group at C-8 and the acetate group at
C-7 attached to the flavones that helped to trigger the GLUT4 expression. Techtochrysin (MN4) and
8-hydroxy-7-methoxyflavone (MN5) showed no significant difference with the non-treated group,
while the rest of the flavonoids showed insignificant upregulated expression as compared to the
non-treated group (p > 0.05). For the expression of C/EBP-α, 8-hydroxy-7-methoxyflavone (MN5)
showed the highest expression, followed by norwogonin (MN7), acetate of norwogonin (MN8), methyl
ether of wogonin (MN2), techtochrysin (MN4), wogonin (MN1), and chrysin (MN6) (p < 0.05). The rest
of the flavonoids showed downregulation of C/EBP-α expression (p > 0.05). The loss of synergism
between GLUT 4 and C/EBPα was observed and it can be suggested that GLUT4 and C/EBP-α have a
weak interaction between each other.
4.3. In Silico Molecular Docking Using GLUT 1
Glucose transporter 1 (GLUT1) belongs to a family of homologous sugar transporters or
cotransporters found in both prokaryotes and eukaryotes. It is a uniporter that transports glucose
from the extra cellular membrane into cells [50]. GLUT1 is the ubiquitous glucose transporter in the
human body and is absolutely essential for cell viability [51]. Crystallized structure of GLUT-4 is
yet to be discovered. Hence, owing to the same fact, GLUT 1, an isoform of GLUT 4, was chosen
for the molecular docking as a representative of the glucose transporter receptor to understand the
mechanism of action of the tested flavonoids through in silico studies [52,53]. Human GLUT 1 and
GLUT 4 share approximately 68.7% of amino acids identity as computed using the Biopolymer module
of Tripos [54]. Flavonoids showing good glucose uptake and Western blotting effects were chosen for
in silico molecular docking study. Among the eight flavonoids docking scores of GLUT 1 receptor
indicated by free binding energies, acetate of wogonin (MN3) showed the highest docking score
(−7.84 kcal/mol) followed by acetate of norwogonin (MN8) (−7.45 kcal/mol), norwogonin (MN7)
(−7.17 kcal/mol), wogonin (MN1) (−7.07 kcal/mol), methyl ether of wogonin (MN2) (−6.97 kcal/mol)
and techtochrysin (MN4) (−6.8 kcal/mol). Both kaempferol (MN11) and (-)-epicatechin (MN14) have
already been reported to exert the inhibitory effect against GLUT4 [55] and therefore served as the
negative control against the GLUT1 receptor in this study. The results showed weak binding energy of
kaempferol and (-)-epicatechin, which were at 7.63 kcal/mol and 7.86 kcal/mol, respectively.
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Methyl ether of wogonin (MN2), acetate of wogonin (MN3) and techtochrysin (MN4) displayed
binding interactions with the residues that interact with glucose in the active site, viz., Asn415,
Trp412 and Trp418. Wogonin (MN1) displayed additional interaction with Gln288 and Gln 282 while
flavone-5,7,8-triacetate showed hydrogen bonding with Gln288 and Gln 282, Pro385 and Glu380.
The interactions of these flavonoid derivatives with Trp412 and Trp388 which was not observed in
the case of glucose might have accounted for the agonist effect of these molecules towards the GLUT1
protein. Moreover, acetate of norwogonin (MN8) exhibited binding interactions similar to that of
acetate of wogonin (MN3). Hydrogen bonding interactions with Asn411, Asn288, Trp388, Asn317,
Pro385 and Glu380 were exhibited by acetate of norwogonin (MN8), whereas, norwogonin (MN7)
formed hydrogen bonding interactions with fewer amino acids which include Asn288, Gln283, trp415
and Trp388. For kaempferol (MN11) ligand, hydrogen bonding interactions with Asn288, Gln282,
Gln283, Asn411 and Gly408 were exhibited, however, for (-)-epicatechin (MN14), hydrogen bonding
interactions with Asn288, Gln282, Asn411, Asn288, Gly408 and Ser30 were observed. Both compounds
displayed hydrophobic interactions with Trp412. Both compounds also showed fewer similarities of
bonding interaction with the co-crystallized ligand as compared with the bonding interactions of the
other which explained the weak free-binding energy against the receptor. The flavonoids bind to the
inner polar region of the active site. Unlike the inhibitors of GLUT1 such as cytochalasin B, which
are bulky molecules that occupy the larger portion of the GLUT1 active site to exert their inhibitory
effect, flavonoids are smaller molecules. This perhaps could indubitably explain why these flavonoids
activated the glucose transport protein instead of exerting an inhibitory effect.
From SAR perspectives, results of cell culture, molecular and in silico assays have shown that
the chemical criterion is a fundamental for the bioactivity of these polyphenolic compounds as shown
in Figure 16. The attachment of a methoxy group at position C-8 and acetate group at C-7 are the
remarkable determinants for adipogenesis and glucose uptake activities via the glucose transporter
(GLUT4) mechanism rather than the flavan backbone alone. Moreover, configuration of the functional
group at positions C-5, C-7 and C-8 has carried significant role in antidiabetic activities. SAR of
wogonin and its derivatives by [56] have earlier reported similar findings, where the methoxy group
(C-8) as well as free phenol groups at positions C-5 and C-7 play very important roles for its bioactivity
(anti-inflammatory activity). Meanwhile, Nicolle et al. [14] have reported that methoxy group at
C-5 leads to a better antidiabetic activity of flavonoids via sodium glucose cotransporter-2 inhibitor.
The present study agreed to the fact that positions C-5, C-7, and C-8 are the essential positions,
and therefore these positions need to be conjugated/configured with appropriate functional groups
i.e., methoxy and acetate groups to enhance the antidiabetic effect via glucose uptake activity.
Figure 16. Methyl and acetate groups act as the key role in the antidiabetic activity for the glucose
uptake mechanism.
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5. Conclusions
Flavonoids are one of the most important groups of bioactive compounds among secondary
metabolites. We have reported antidiabetic activities of some selected flavonoids from in vitro and in
silico perspectives. The present study concludes that tested flavonoids have shown in vitro antidiabetic
activities through improved insulin secretion, upregulatory activity of glucose uptake, regulating
adipokines secretion, and activation of glucose transporter (GLUT4). The results of this study have
further enabled us to understand the key pharmacophores of flavonoids via a SAR study and should be
encouraged for further studies, which could ultimately lead to the development of nutritional products
and semi-synthetic analogs that retain substantial antidiabetic capacities with minimal adverse effects.
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